Skip to content

Online Measurement of Cognitive functioning in patients with cancers with CNS involvement

Online Measurement of Cognitive functioning in patients with cancers with CNS involvement - OMCog-CNS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON51344
Enrollment
100
Registered
2022-07-20
Start date
2022-04-19
Completion date
Unknown
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive deficits memory and concentration problems

Interventions

None listed

Sponsors

Antoni van Leeuwenhoek Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients diagnosed with >= 1 brain metastases Scheduled for, or treated with stereotactic radiotherapy Age range 18-89

Exclusion criteria

Exclusion criteria: Insufficient command of the Dutch language

Design outcomes

Primary

MeasureTime frame
We will calculate completion rates for the classical neuropsychological test outcomes and for the ACS test outcomes. The completion rate for each test outcome of the ACS, is considered acceptable when at most 10% lower than the completion rate of the equivalent classical neuropsychological test.

Secondary

MeasureTime frame
n.a.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)